01 January 2008
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski, M. D. PescovitzAnn Transplant 2008; 13(1): 23-23 :: ID: 880177
Abstract
For immunosuppressive drugs the most accurate estimate of drug exposure is provided by the dose-interval area under the concentration vs time curve (AUC) at steady-state. Since the most accurate determination of the dose-interval AUC is obtained using a full set of timepoints throughout the dose interval involving usually from approximately 8 to 12 or more timed samples, this approach is not practical for routine clinic patients, or for newly transplanted inpatients nor for patients enrolled in clinical studies. Thus the importance of establishing in the most rigorous manner possible limited sampling strategies (LSS) for reliable estimation of the immunosuppressant drug AUC is both an important scientific and practical challenge. In this presentation a description of our approach and experience in developing LSS models for mycophenolic acid AUC estimation will be provided. Included in this presentation will be description of a cross-validation approach to developing the estimation models using the general linear model procedure in the statistical program SAS. The discussion will focus on our recent experience in developing LSS models for MPA AUC estimation in patient receiving either concomitant CsA or sirolimus.
Keywords: immunosuppressive drugs, Mycophenolic Acid, pancreati
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860